50 million seniors age 60 and over to get Zostavax to prevent shingles
New recommendations will call for about 50 million seniors age 60 and over to get Zostavax to prevent shingles.
This new vaccine reduces the RELATIVE risk of shingles by about 50% and the ABSOLUTE risk by 1.7%. It also reduces the relative risk of postherpetic neuralgia by 67%...since fewer people get shingles.
There are no significant side effects for most people.